Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Archives of Oto-Rhino-Laryngology

Open Access 06-05-2024 | Dyspnea | Laryngology

Mapping quality of life after balloon dilatation in subglottic stenosis using Dyspnea index and Short Form Health Survey-36

Authors: Anders Erlandsson, Anders Lundquist, Katarina Olofsson

Published in: European Archives of Oto-Rhino-Laryngology

Login to get access

Abstract

Purpose

An accurate diagnosis and proper treatment plan are required to restore an adequate patent airway in fibrotic subglottic stenosis (SGS). Currently, the definitive treatment entails single-stage balloon dilatation with steroid injections. The primary aim was to evaluate successful airway restoration and general quality of life in cases with SGS in northern Sweden using robust patient reported outcomes.

Methods

All participants with need of surgical treatment due to SGS that had been referred to the department of otorhinolaryngology, University Hospital of Umeå from September 2020 to August 2023 was included. Exclusion criteria included malignant, extrathoracic or cartilaginous cause, age < 18 years, or incompetent to sign consent documents. We assessed the patient-reported outcome measures pre- as well as 3 months postoperatively.

Results

Of the 40 cases fulfilling the eligibility criteria’s, 33 cases completed the Dyspnea index (DI) and the short form health survey (SF-36) pre- as well as 3 months post-operatively. Receiver operating characteristics showed significant improvement in DI as well as in SF 36 scores post-operatively.

Conclusions

Evaluation of balloon dilatation in SGS in this cohort follow-up analysis shows clear improvement in patient quality of life using robust PROM 3 months postoperatively, ensuring the use of a safe and well-tolerated procedure.
Literature
1.
Nunn AC, Nouraei SAR, George PJ et al (2014) Not always asthma: clinical and legal consequences of delayed diagnosis of laryngotracheal stenosis. Case Reports in Otolaryngology 2014:1–5CrossRef
2.
Berges AJ, Lina IA, Chen L et al (2022) Delayed diagnosis of idiopathic subglottic stenosis. Laryngoscope 132(2):413–418CrossRefPubMed
3.
4.
Yin LX, Padula WV, Gadkaree S et al (2019) Health care costs and cost-effectiveness in laryngotracheal stenosis. Otolaryngol Head Neck Surg 160(4):679–686CrossRefPubMed
5.
Aarnæs MT, Sandvik L, Brøndbo K (2017) Idiopathic subglottic stenosis: an epidemiological single-center study. Eur Arch Otorhinolaryngol 274(5):2225–2228CrossRefPubMedPubMedCentral
6.
7.
Tierney WS, Huang LC, Chen SC et al (2023) Comparative treatment outcomes for idiopathic subglottic stenosis: 5-year update. Otolaryngol Head Neck Surg 168:1570–1575CrossRefPubMed
8.
Hoffman MR, Patro A, Huang LC et al (2021) Impact of adjuvant medical therapies on surgical outcomes in idiopathic subglottic stenosis. Laryngoscope 131:E2880–E2886CrossRefPubMedPubMedCentral
9.
Naunheim MR, Paddle PM, Husain I et al (2018) Quality-of-life metrics correlate with disease severity in idiopathic subglottic stenosis. Laryngoscope 128(6):1398–1402CrossRef
10.
Gartner-Schmidt JL, Shembel AC, Zullo TG et al (2014) Development and validation of the Dyspnea Index (DI): a severity index for upper airway-related dyspnea. J Voice 28(6):775–782CrossRefPubMed
11.
Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483CrossRefPubMed
12.
Ntouniadakis E, Brus O, von Beckerath M (2021) Dyspnea Index: an upper airway obstruction instrument; translation and validation in Swedish. Clin Otolaryngol 46(2):380–387CrossRefPubMedPubMedCentral
13.
14.
Tie K, Buckmire RA, Shah RN (2020) The role of spirometry and Dyspnea index in the management of subglottic stenosis. Laryngoscope 130(12):2760–2766CrossRefPubMed
15.
Samad I, Akst L, Karatayli-Özgürsoy S et al (2016) Evaluation of Dyspnea outcomes after endoscopic airway surgery for laryngotracheal stenosis. JAMA Otolaryngol Head Neck Surg 142(11):1075CrossRefPubMedPubMedCentral
16.
Ntouniadakis E, Sundh J, Soderqvist J et al (2023) How can we identify subglottic stenosis in patients with suspected obstructive disease? Eur Arch Otorhinolaryngol 280(11):4995–5001CrossRefPubMedPubMedCentral
17.
Song SA, Santeerapharp A, Choksawad K et al (2020) Reliability of peak expiratory flow percentage compared to endoscopic grading in subglottic stenosis. Laryngosc Investig Otolaryngol 5(6):1133–1139CrossRef
18.
Alrabiah A, Almohanna S, Aljasser A et al (2022) Utility of spirometry values for evaluating tracheal stenosis patients before and after balloon dilation. Ear Nose Throat J 101(2):62–67CrossRef
19.
Ntouniadakis E, Sundh J, Magnuson A et al (2023) Balloon dilatation is superior to CO(2) laser excision in the treatment of subglottic stenosis. Eur Arch Otorhinolaryngol 280(7):3303–3311CrossRefPubMedPubMedCentral
Metadata
Title
Mapping quality of life after balloon dilatation in subglottic stenosis using Dyspnea index and Short Form Health Survey-36
Authors
Anders Erlandsson
Anders Lundquist
Katarina Olofsson
Publication date
06-05-2024
Publisher
Springer Berlin Heidelberg
Keywords
Dyspnea
Dyspnea
Published in
European Archives of Oto-Rhino-Laryngology
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-024-08667-0